About gadodiamide
Gadolinium-based MRI contrast agent
Used for
- Enhances MRI images of the brain, spine, and other body areas.
- Helps identify or assess abnormal tissues and blood vessels.
Usual adult dose
Usually 0.1 mmol/kg by intravenous injection; dose may vary by examination.
Usual dose in children
Usually 0.1 mmol/kg intravenously for approved MRI examinations; use depends on age and local labeling.
Common side effects
- Headache
- Nausea
- Dizziness
- Injection-site discomfort
Important warnings
- Rare severe allergic reactions can occur.
- May cause nephrogenic systemic fibrosis in people with severe kidney problems.
- Gadolinium can remain in the body after administration; avoid unnecessary repeat scans.
- Use only when the MRI benefit outweighs potential risks.
Pregnancy
Avoid unless essential; use during pregnancy only when clearly needed.
Breastfeeding
Breastfeeding can generally continue after administration; discuss individual circumstances with a clinician.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.